Frontotemporal Lobar Degeneration Clinical Trial
Official title:
Psycho-behavioral Disorders in Frontotemporal Lobar Degeneration: Validation of a Quantification and Follow-up Scale
Psycho-behavioral disorders assessment is crucial for the diagnosis and follow-up of patients with frontotemporal degeneration (FTD). DAPHNE scientific staff have therefore developed a quantification and follow-up scale specifically dedicated to patients with FTD in current clinical practice. This scale is called DAPHNE to Disinhibition, Apathy, Perseveration, Hyper orality, Negligence and loss of Empathy.
Psycho-behavioral disorders assessment is crucial for the diagnosis and follow-up of patients with frontotemporal degeneration (FTD). DAPHNE scientific staff have therefore developed a quantification and follow-up scale specifically dedicated to patients with FTD in current clinical practice. This scale is called DAPHNE to Disinhibition, Apathy, Perseveration, Hyperorality, Negligence and loss of Empathy. This study aims to validate this scale. This validation will include methodological steps required to develop a new clinical tool, by studying internal consistency, loyalty, and concurrent validity in comparison with validated existing tools. Complementarily, sensitivity and specificity will be assessed via a control population including patients with Alzheimer's disease, , progressive supranuclear palsy and bipolar disorder with cognitive disorders. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01925196 -
Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation
|
||
| Active, not recruiting |
NCT04516499 -
Neurofilament Surveillance Project (NSP)
|
||
| Recruiting |
NCT05456503 -
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using PI-2620
|
Phase 3 | |
| Recruiting |
NCT03030586 -
ADDIA Proof-of-Performance Clinical Study
|
||
| Completed |
NCT02590276 -
Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS)
|
N/A | |
| Completed |
NCT00677885 -
P-glycoprotein Function in Brain Diseases
|
||
| Completed |
NCT02333942 -
Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
|
||
| Completed |
NCT00187525 -
A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration
|
Phase 4 | |
| Recruiting |
NCT05741853 -
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
|
N/A | |
| Completed |
NCT04287738 -
Care Ecosystem: Navigating Patients and Families Through Stages of Care, Extension Trial
|
N/A | |
| Completed |
NCT02213458 -
Care Ecosystem: Navigating Patients and Families Through Stages of Care
|
N/A | |
| Active, not recruiting |
NCT04937452 -
Dopaminergic Therapy for Frontotemporal Dementia Patients
|
Phase 2 | |
| Completed |
NCT03606798 -
Multidisciplinary and Personalized Care of Behavioral Disorders in Frontotemporal Lobar Degeneration.
|
N/A | |
| Recruiting |
NCT01962064 -
Social Cognition in Ageing and in Frontotemporal Lobar Degeneration
|
N/A | |
| Recruiting |
NCT05956834 -
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
|
||
| Completed |
NCT00088751 -
Treatment Study of Frontotemporal Dementia
|
N/A | |
| Enrolling by invitation |
NCT04635540 -
Decreased Empathy and Emotion Recognition in Patients With Neurodegenerative Disease
|
N/A | |
| Completed |
NCT00604591 -
Effects of Tolcapone on Frontotemporal Dementia
|
Phase 2 | |
| Completed |
NCT03508024 -
Patients With Alzheimer's Disease or Related Youth Disease
|
||
| Completed |
NCT00613119 -
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia
|